Fundraising Fox
Lyra Therapeutics
Founded 2018 · 25 employees on LinkedIn · 1 known investors
Find your way into Lyra Therapeutics
Sign up to find every way you can get introduced to Lyra Therapeutics
- Your email: who you already know at Lyra Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lyra Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.
Investors · 1
Frequently asked questions
- What does Lyra Therapeutics do?
- Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.
- Who are Lyra Therapeutics's investors?
- Lyra Therapeutics's investors include Broadview Ventures.